Citation Impact
Citing Papers
A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies
2017
Noninvasive Detection of Response and Resistance in EGFR -Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
2014
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
2010
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
2011
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
2011
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Inhibition of Oncogenic Epidermal Growth Factor Receptor Kinase Triggers Release of Exosome-like Extracellular Vesicles and Impacts Their Phosphoprotein and DNA Content
2015
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
2012
A view on drug resistance in cancer
2019 StandoutNature
Breast cancer
2016 Standout
Genetically engineered mouse models of pancreatic adenocarcinoma
2013
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
2010
The biology and management of non-small cell lung cancer
2018 StandoutNature
Rituximab
2003
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Lung Cancer
2008 Standout
Translating cancer research into targeted therapeutics
2010 Nature
Targeted treatments in colorectal cancer: state of the art and future perspectives
2010
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
2009
Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
2010
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Colorectal cancer
2013 Standout
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
2010 StandoutNature
Antibodies in oncology
2011
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity
2009
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
2012 Nature
Targeted therapies in bladder cancer: an overview of in vivo research
2015
Personalized medicine: Time for one-person trials
2015 Nature
Lung cancer: current therapies and new targeted treatments
2016 Standout
Pancreatic Adenocarcinoma
2014 Standout
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
2019
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
2012
Bladder cancer
2016 Standout
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
2012 Nature
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
2012
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
2014
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
2012 Standout
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Cancer immunotherapy comes of age
2011 StandoutNature
N-Glycoprotein SRMAtlas
2013
Biomarkers of response and resistance to antiangiogenic therapy
2009
Microtubules as a target for anticancer drugs
2004 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
The PI3K Pathway in Human Disease
2017 Standout
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
2013
Review of clinical radioimmunotherapy
2006
Reassessment of Exosome Composition
2019 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
2015
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Hepatocellular carcinoma
2022 Standout
Targeted Therapies for Hepatocellular Carcinoma
2011
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
2010
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
2008
Obesity and Cancer Mechanisms: Cancer Metabolism
2016
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
2015
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
2011
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
2011
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
2012
Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma
2009
A Decade of Rituximab: Improving Survival Outcomes in Non-Hodgkin's Lymphoma
2008
Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
2010
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
2009
Nanomaterials for Cancer Precision Medicine
2018
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
2008
A New Initiative on Precision Medicine
2015 Standout
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
2010
Cancer Genome Landscapes
2013 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The serrated pathway to colorectal carcinoma: current concepts and challenges
2012
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
2016
Works of Haji Chalchal being referenced
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32
2015
Phase II study of PX-866 in recurrent glioblastoma
2015
Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer
2009
Rituximab Therapy for Patients With Newly Diagnosed, Advanced-Stage, Follicular Grade I Non-Hodgkin's Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group
2005